SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

Ginkgo Bioworks Holdings, Inc. (DNA) News

Follow Ginkgo Bioworks Holdings, Inc. (DNA) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 12 public stories across 8 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol DNA Asset equity Sector Markets 90 days 10 Last 7.45 Updated Nov 05, 2026, 10:33 PM UTC Open live news feed Open DNA chart & news
M Ginkgo Bioworks Reports Q3 Revenue of $27.711 Million Q3 revenue fell 5.7% year over year to $27.711 million. Net loss narrowed to $40.984 million, or $0.64 per share, from $80.755 million, or $1.45 per share. The company reported its first autonomous lab platform sale and EQUITY | Nov 05, 2026, 10:33 PM UTC M Ginkgo Bioworks Q3 Revenue Falls Year Over Year EQUITY | Nov 05, 2026, 09:46 PM UTC M Ginkgo Bioworks Reports Third-Quarter Results, Signs First Autonomous Lab Sale Ginkgo Bioworks reported results for the quarter ended September 30, 2026, and signed its first autonomous lab sale to a top-tier pharmaceutical company. EQUITY | Nov 05, 2026, 09:16 PM UTC H Glaukos Reveals Superior Intraocular Pressure Reduction With Novel Eye Therapy Ophthalmic pharmaceutical and medical technology firm Glaukos Corporation (NYSE: GKOS ) reported successful topline outcomes from its latest Phase 4 clinical study. The trial evaluated the effectiveness of administering LIVE | Oct 09, 2026, 04:49 PM UTC H Humana, Evolution Metals & Technologies, Fastly And Other Big Stocks Moving Higher On Friday U.S. stocks were higher, with the Nasdaq Composite gaining around 100 points on Friday. Shares of Humana Inc (NYSE: HUM ) rose sharply after the company said Friday that its 2027 Medicare Advantage Star Ratings improved LIVE | Oct 09, 2026, 02:51 PM UTC H Apogee Enterprises Posts Upbeat Q2 Earnings, Joins Constellation Energy, Freshworks And Other Big Stocks Moving Higher On Tuesday U.S. stocks were higher, with the Dow Jones index surging over 250 points on Tuesday. Shares of Apogee Enterprises Inc (NASDAQ: APOG ) rose sharply after the company announced better-than-expected second-quarter financia LIVE | Oct 06, 2026, 02:20 PM UTC L DNA - Ginkgo Datapoints Announces Partnership with TuneLab to Close the Gap between AI Models and Lab Data DNA - Ginkgo Datapoints Announces Partnership with TuneLab to Close the Gap between AI Models and Lab Data NEWS | Sep 16, 2026, 01:55 PM UTC M Ginkgo Datapoints signs agreement with Lilly TuneLab Ginkgo Bioworks (NYSE: DNA) says its Ginkgo Datapoints offering entered into a new agreement with Lilly TuneLab, a collaborative AI/ML drug discovery platform created by Eli Lilly and Company. EQUITY | Sep 16, 2026, 01:52 PM UTC M Ginkgo Bioworks awarded up to $17.5M ARPA-H GIVE subcontract Ginkgo Bioworks was awarded a subcontract for up to $17.5M under ARPA-H’s GIVE program. The company will serve as a subcontractor to prime contract holders. EQUITY | Sep 10, 2026, 12:01 PM UTC L BTIG keeps Ginkgo Bioworks price target at $5.00 Benzinga reports BTIG maintained its $5.00 per-share price target for Ginkgo Bioworks Holdings. EQUITY | Sep 04, 2026, 11:12 AM UTC L TEM shares now up over 23% PRME +17% RXRX +11% and DNA about 16%, extending gains all day in Precision Medicine, or Biomedical/genetics sub TEM shares now up over 23% PRME +17% RXRX +11% and DNA about 16%, extending gains all day in Precision Medicine, or Biomedical/genetics sub-areas which have all rallied behind the MRNA/MRK news today EQUITY | Aug 19, 2026, 07:34 PM UTC L Brazil DNA Strengthens Connection Between Brazilian Tourism and the North American Market with Second Edition of International Roadshow São Paulo, Brazil--(. - July 3, 2026) - The second edition of Brazil DNA brought together Brazilian destinations and companies interested in expanding their presence in the United States and C EQUITY | Jul 03, 2026, 07:18 PM UTC